Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve Board meeting intimation
Awaiting price reaction for this filing.
Dolphin Medical Services Ltd has informed BSE that its Board of Directors will meet on 30 January 2026 at the registered office in Hyderabad. The main agenda is to consider and approve the Un-Audited Financial Results for the third quarter ended 31 December 2025. The intimation is filed under Regulation 29 of the SEBI Listing Obligations and Disclosure Requirements, 2015. The notice is signed by Managing Director Dr. Mohan Prasad GV. No financial figures or performance details are disclosed in this filing — those will follow after the board approves the results.
This is a routine advance notice ahead of the company's Q3 results and is not expected to move the stock on its own. Investors should watch for the actual unaudited numbers once released post the 30 January meeting to assess earnings performance and any directional cues.